Functional Characterization Experiment summary for ENCSR802ODH
doi:10.17989/ENCSR802ODH
Summary
- Status
- released
- Assay
- STARR-seq
- Biosample summary
- Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Treatments
- 1 μM ZK216348 for 4 hours
- Nucleic acid type
- RNA
- Library starting quantity
- 75µg
- Size range
- 900-1000
- Extraction method
- Qiagen RNA extraction
- Strand specificity
- Strand-specific (reverse)
- Platform
- Illumina NovaSeq 6000
- Controls
Attribution
ENCODE4 project
- Lab
- Tim Reddy, Duke
- Award
- UM1HG009428 (Tim Reddy, Duke)
- Project
- ENCODE
- Aliases
- tim-reddy:A549-wg-starrseq-ZK216348
- Date submitted
- June 11, 2021
- Date released
- June 17, 2021
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Library |
---|---|---|---|---|---|
1 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS483RTQ | ENCGM016JFT | ENCLB845SCZ |
2 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS452ONW | ENCGM016JFT | ENCLB295CFY |
3 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS544WKC | ENCGM016JFT | ENCLB894JGS |
4 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS606XIB | ENCGM016JFT | ENCLB221VDG |
2 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS452ONW | ENCGM016JFT | ENCLB757CTK |
4 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS606XIB | ENCGM016JFT | ENCLB455OWV |
1 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS483RTQ | ENCGM016JFT | ENCLB692IQT |
4 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS606XIB | ENCGM016JFT | ENCLB663XAM |
1 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS483RTQ | ENCGM016JFT | ENCLB624EJP |
3 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS544WKC | ENCGM016JFT | ENCLB982ZFZ |
1 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS483RTQ | ENCGM016JFT | ENCLB861LSD |
2 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS452ONW | ENCGM016JFT | ENCLB160AGL |
3 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS544WKC | ENCGM016JFT | ENCLB076VEY |
4 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS606XIB | ENCGM016JFT | ENCLB774PNP |
2 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS452ONW | ENCGM016JFT | ENCLB662ATS |
3 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hours | ENCBS544WKC | ENCGM016JFT | ENCLB964XCJ |